BioPharma Dive - Latest News

Novo cuts forecasts as compounded GLP-1s weigh on sales

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

May 7, 2025 - 17:17
 0
Novo cuts forecasts as compounded GLP-1s weigh on sales

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

Read More

Tags:

Previous Article

Mitsubishi Confirms All-New Electric Vehicle Will Be Sold In North America In 2026

Next Article

Vinted becomes investor and launches 'Vinted Ventures'

Related Posts

German antibody maker valued at $1.6B in blank-check merger

German antibody maker valued at $1.6B in blank-check me...

Apr 23, 2025  0

Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously

Facing ‘uncertainty on steroids,’ biotech dealmakers tr...

May 6, 2025  0

Roche looks to a Flagship startup in search of new immune drugs

Roche looks to a Flagship startup in search of new immu...

Apr 23, 2025  0